Retatrutide

$400.00$600.00
Dose
icon-delivery Delivery !
  • Processing Notice
    Research Kits are made-to-order.
    Allow 7–10 Business Days for processing prior to shipment.
  • Secure, discreet packaging.
    Tracking provided once shipped.
Return Policy Learn More
Description

Retatrutide — 100mg Kit of 10

GLP3-R is a novel triple agonist peptide targeting GIP (glucose-dependent insulinotropic polypeptide), GLP-1 (glucagon-like peptide-1), and glucagon receptors. This multi-pathway approach is being studied for its potential to enhance energy expenditure, metabolic regulation, and body composition optimization. Retatrutide has demonstrated unique properties in preclinical research related to glucose homeostasis, lipid metabolism, and weight management through simultaneous incretin and glucagon receptor activation.

The Method

≥99% purity. Third-party tested. Sterile vials. Trusted quality.

Contents: 100mg total active Retatrutide per kit (10 vials)

Composition per vial: Retatrutide (10mg)

Storage: Keep refrigerated after reconstitution.

For Research Use Only. Not for human consumption.

Highlights

Triple receptor agonist studied for comprehensive incretin and glucagon pathway activation

Investigated for effects on energy balance, glucose metabolism, and lipid oxidation

Supports advanced research in obesity, metabolic health, and endocrine modulation

High-purity, lyophilized peptide formulation for laboratory studies

Complete 10-vial kit for extended metabolic and physiological research

Storage Information

Form: Lyophilized powder (white to off-white)

Dry powder (unreconstituted): Stable at –4 °F (–20 °C) for up to 24 months when sealed, dry, and protected from light

Reconstituted solution: Store at 36–46 °F (2–8 °C) and use within 30 days

Avoid repeated freeze–thaw cycles to maintain peptide stability

CAS

Chemical Name: Retatrutide
Molecular Formula: C₂₆₇H₄₀₅N₆₅O₈₁
Molecular Weight: 5900.67 g/mol
CAS Number: 2381089-83-2
Synonyms: LY3437943, Triple GIP/GLP-1/Glucagon Receptor Agonist

By Method Peptides